Ag-Ab reaction

Antigen-Antibody Interactions

Introduction

  • Antigens and antibodies combine specifically with each other, leading to an interaction called the Antigen-Antibody reaction (Ag-Ab reaction).
  • This interaction forms the basis for:
    • Humoral immunity or antibody-mediated immunity.
    • Detection of infectious disease-causing agents and non-specific antigens like enzymes.

Serological Reactions

  • When Ag-Ab reactions occur in vitro, they are referred to as serological reactions.
  • The reactions between antigens and antibodies occur in three stages:
    1. Stage 1: Involves the formation of an Ag-Ab complex.
    2. Stage 2: Leads to visible events such as precipitation and agglutination.
    3. Stage 3: Involves the destruction of the antigen or its neutralization.

Salient Features of Antigen-Antibody Reaction

  • Specificity of Antigen-Antibody Reaction:
    • Refers to the unique ability of an antibody to combine with only one specific antigenic determinant (or epitope).
  • Immune Complex:
    • An immune complex is formed when an antibody binds to a soluble antigen. Here, the bound antigen acts as a specific epitope.
  • Binding Site of Antigen-Antibody Reaction:
    • The site where the antigen binds to the antibody is crucial for the reaction to occur.
  • Binding Force of Antigen-Antibody Reaction:
    • The interaction relies on various binding forces and the specificity of the antibody.

Specificity of Antigen-Antibody Reaction

  • Definition: Specificity refers to the selectiveness of an individual antibody binding site to react with only one antigenic determinant, ensuring that each antibody binds to a specific antigen.
    • This interaction can be likened to a lock-and-key mechanism, where the antibody (key) fits into its specific antigen (lock).
  • Example:
    • An antibody produced against lens antigen will only react with lens antigen, similar to how a standard key opens only its designated lock.

Immune Complex

  • An immune complex forms through the integral binding of an antibody to a soluble antigen.
  • The antigen-serving as a specific epitope when bound to an antibody is called a singular immune complex.

Mechanisms of Antigen-Antibody Interaction

  • Antigen-antibody immune complex formation causes:
    • Complement Activation: Activation of the complement system, which plays a crucial role in inflammation and immune responses.
    • Opsonization of Target Cells: Tagging pathogens for destruction by immune cells.
    • Assembly of Membrane Attack Complexes: Leading to perturbation of target cell membranes.
    • Release of Complement Activators: Prompting chemotactic responses that recruit more immune cells.
  • Fc Receptor Mediated Cell Activation:
    • Triggers responses such as phagocytosis, antibody-dependent cellular cytotoxicity (ADCC), and release of inflammatory mediators.

Binding Site of Antigen-Antibody Reaction

  • In these reactions, antibodies attach to antigens. The part of the antigen that interacts with the antibody is called an Epitope (antigenic determinant).
  • The corresponding part of the antibody that recognizes the epitope is termed a Paratope.
Structure of Antigen and Antibody
  • Antigen: The substance that elicits an immune response.
  • Antibody: The protein produced by the immune system to bind to specific antigens.

Binding Force of Antigen-Antibody Reaction

  • The strength of the binding in Ag-Ab reactions can be characterized by three factors:
    1. Closeness: The proximity between antigen and antibody enhances the binding strength.
    2. Non-Covalent Bonds:
    • Bonds involved are non-covalent in nature, including:
      • Hydrogen Bonds
      • Electrostatic Bonds
      • Van der Waals Forces
      • Hydrophobic Bonds
    1. Affinity of Antibody:
    • The affinity of an antibody denotes its strength of interaction with a particular antigenic determinant.

Strength of Antigen-Antibody Reaction

  • The basis of antigen-antibody binding includes several non-covalent interactions, specifically:
    • Hydrogen Bonds
    • Ionic Bonds
    • Hydrophobic Interactions
    • Van der Waals Interactions
Visual Representation of Interactions
  • Diagrams may show interactions including the arrangement of specific non-covalent bonds between antigens and antibodies.

Types of Antigen-Antibody Reaction

  • Various types of antigen-antibody reactions include:
    1. Precipitation Reactions: Formation of insoluble complexes.
    2. Agglutination Reactions: Clumping of particles.
    3. Complement Fixation: Activation of the complement system following binding.
    4. ELISA (Enzyme Linked Immunosorbent Assay): A method for detecting and quantifying proteins and antibodies.
    5. Immunofluorescence: Technique for visualizing the presence of antigens using fluorescent dyes.

Application of Antigen-Antibody Reaction

  • Key uses of antigen-antibody interactions include:
    • Determination of blood types for transfusions.
    • Serological ascertainment of exposure to infectious agents.
    • Development of immunoassays for quantifying substances.
    • Detection of proteins in serum samples.
    • Characterization of specific immunodeficiency diseases.

Blood Coagulation

Steps in Hemostasis

  • Platelet Plug Formation:
    • Stage Details:
      a. Platelets attach to exposed collagen at the site of a blood vessel injury.
      b. Aggregation of platelets: This action causes the release of chemical mediators such as ADP and Thromboxane A2.
      c. ADP: Attracts more platelets to the site of injury.
      d. Thromboxane A2: A powerful vasoconstrictor that promotes further aggregation of platelets and increases ADP release.
Diagram Representation
  • A diagram may illustrate:
    • The structure and interaction of platelets, vessel lumen, and chemicals (e.g., prostacyclin, ADP, Thromboxane A2) during hemostasis.

Stages of Coagulation

  • Main stages include:
    1. Formation of Prothrombinase.
    2. Thrombin formation.
    3. Fibrin formation.
Clotting Cascade
  • The clotting cascade involves:
    • Participation of 12 different clotting factors (plasma glycoproteins) designated by Roman numerals.
    • Cascade of proteolytic reactions leading to the common pathway that forms a fibrin clot.

Hemostasis - Coagulation

  • Stage 1: Prothrombinase Formation:
    • Catalyzes the conversion of prothrombin to thrombin.
    • Has two pathways:
    1. Extrinsic Pathway:
      • Rapid activation (within seconds) through tissue factor (TF) from damaged tissue.
    2. Intrinsic Pathway:
      • Slower activation (minutes) through blood activators from damaged cells.
    • Both pathways ultimately activate prothrombinase, and Ca2+ is required for activation.
Stage 2 and 3 - Common Pathway
  • Thrombin Formation:
    • Requires prothrombinase and Ca2+ ions, leading to the conversion of prothrombin to thrombin.
  • Fibrin Formation:
    • Activated thrombin catalyzes the conversion of soluble fibrinogen to insoluble fibrin, forming the structural basis of the clot.
Diagrammed Pathways
  • Detailed diagrams may show components involved in both the extrinsic and intrinsic pathways leading to thrombin and fibrin formation.

Clot Dissolution

  • Clots are slowly dissolved by the enzyme Plasmin, which is derived from its precursor Plasminogen.
  • Plasmin, trapped in the clot, breaks down the fibrin meshwork, contributing to the clot resolution process.

Fibrinolysis

  • Factors converting plasminogen to plasmin include:
    • Thrombin
    • Activated Factor XII
    • Tissue Plasminogen Activator (t-PA)

Anticoagulant Factors

  • Anticoagulant Factors:
    • Include:
    • Antithrombin III
    • C-protein
    • Alpha-macroglobulin
    • C1 Inactivator
    • Heparin